Gene Panel Market Overview
A gene panel is a type of test that
helps to examine several genes simultaneously for cancer-associated mutations.
This test is capable of evaluating a variety of genes that can provide cancer
information to provide an accurate diagnosis to help prevent or stop the spread
of cancer.
According to Market Research Future
(MRFR), the global gene panel market is projected to cross USD 4.347.32 million
with a CAGR of 12.16% by 2018 to 2025 (forecast period). The report is a broad
combination of qualitative and quantitative information that illustrates key
business developments, issues affecting industry and competition, as well as
developments in the gene panel market.
Get a FREE Sample with Complete TOC By
Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6100
Gene Panel Market Dynamics
Owing to the rise in the incidence of
chronic diseases worldwide, the global market for gene panels is expected to
expand significantly. The increase in the number of company initiatives
worldwide and the advantages of the gene panels are major factors expected to
fuel the market for the gene panel during the forecast period. However, in the
coming years, stringent rules and regulations for pharmaceutical companies and
health problems related to genetic data are likely to impede the gene panel
market. However, ongoing research and development in the field of gene
sequencing are expected to pose substantial market growth opportunities during
the forecast period.
Gene Panel Market Segmentation
The global market gene panel market has
been segmented by product & service, technology, design, application, and
end-user.
Based on product & service, the
market has been split into test kits and test services.
Based on the technology, the global
market for gene panels has been bifurcated into an amplicon-based approach and
a hybridization-based approach.
Based on the design, the global market
for gene panels was divided into pre-designed gene panels and customized gene
panels.
Based on the application, the global
market for gene panel was listed as a cancer risk assessment, congenital
condition diagnosis, and pharmacogenetics.
Based on end-user, the market for gene
panel was divided into hospitals, diagnostic laboratories, and others.
Gene Panel Market Regional
Analysis
Region-wise, the global market for gene
panel was divided into North America, Europe, the Asia Pacific, and the Middle
East & Africa.
North America is further divided into
the United States and Canada. The United States of America is likely to be
leading the global demand for gene panels. It can be due to the increasing
prevalence of cancer in the region. Almost 1,688,780 new cases were reported in
the US in 2017.
The European gene panel market is
expected to be second-largest during the forecast period. The incidence rate
for all cancers is expected to increase by 2% in the United Kingdom to 742
cases per 100,000 people between 2014 and 2035. This increasing cancer case,
combined with the improved performance of the gene panel, is expected to drive
market development.
Due to the rising expenditure on
healthcare and the presence of a broad patient pool, the Asia Pacific market is
projected to have a significant growth rate during the forecast period.
The Middle East & Africa market is
expected to grow due to increasing healthcare spending, increasing investment
by major market players, and growing patient pools in this region. For example,
according to the International Trade Administration, expenditure in the UAE
amounted to USD 17 billion in 2017 and is projected to reach USD 21.3 billion
by 2021.
Gene Panel Market Key
Players
The key players in the global gene
panel market are Agilent Technologies Inc. (US), Thermo Fisher Scientific (US),
F. Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany), Illumina Inc. (US),
BGI Genomics (China), Integrated DNA Technologies, Inc. (the US), GENEWIZ (US),
Novogene Corporation (US), Personalis, Inc. (US), GATC Biotech AG (Germany),
ArcherDX, Inc. (the US), GeneDx (Switzerland), and CENTOGENE AG
(Germany).
Gene Panel Industry News
In October 2019, Qiagen and Illumina (US) stated a 15-year
agreement to widen the development and use of NGS-based in vitro diagnostic
(IVD) kits for patient management and companion diagnostics. This collaboration
has become a significant component of Qiagen's NGS strategy, which tends to
include universal solutions for use with any sequencer, as well as the
GeneReader NGS System for use primarily with smaller, targeted gene panels.
Obtain Premium Research Report Details,
Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/gene-panel-market-6100
About Market Research Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and
Market Research & Consulting Services.
MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients. Our market research studies by Components, Application, Logistics and
market players for global, regional, and country level market segments, enable
our clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with
technology and work process of the industry, MRFR often plans & conducts
meet with the industry experts and industrial visits for its research analyst
members.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
No comments:
Post a Comment